CAMP (CAMP) Stock

Healthcare · Biotechnology · Member of Other US Stocks

CAMP (CAMP) closed at USD 3.43 on 2026-10-14, a change of -12.3 % over the past year, with a market capitalization of USD 216.5M.

CAMP recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

CAMP key figures

Previous close

USD 3.43 (2026-10-14)

1-year change

-12.3 %

Market cap

USD 216.5M

Enterprise value

USD 132.47M

P/E ratio (trailing)

-1.49

P/E ratio (forward)

-4.27

EPS (trailing)

-2.32

EPS (forward)

-0.81

PEG ratio

n/a

Price to book

-265.38

Revenue growth

18.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.25

Employees

48

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About CAMP

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for CAMP and compare it with other stocks.